Cargando…

Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial

BACKGROUND: Medium or large coronary artery aneurysm (CAA) is a serious complication of Kawasaki disease (KD) and may cause thrombosis, coronary artery stenosis, and even myocardial infarction at different stages of the disease. Dual antiplatelet therapy (aspirin plus clopidogrel) is considered for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dan, Chen, Xi, Li, Xiaohui, Yuan, Yue, Jin, Hongfang, Liu, Guiying, Zhang, Huili, Xie, Gaoqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349963/ https://www.ncbi.nlm.nih.gov/pubmed/34430440 http://dx.doi.org/10.21037/tp-21-74

Ejemplares similares

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
por: Samaniego, Edgar A, et al.
Publicado: (2019)

Coronary artery aneurysm in Kawasaki disease
por: Donuru, Achala, et al.
Publicado: (2020)

Beaded Coronary Aneurysm in Kawasaki Disease
por: Tai, I-Hsin, et al.
Publicado: (2022)

Atipical kawasaki disease with coronary aneurysm in infant
por: Dodi, Icilio, et al.
Publicado: (2011)

Segmented Coronary Artery Aneurysms and Kawasaki Disease
por: Moghadam, Mohammad Yoosef Aarabi, et al.
Publicado: (2011)

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial
por: Helft, Gérard, et al.
Publicado: (2013)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

High risk of coronary artery aneurysm in Kawasaki disease
por: Mossberg, Maria, et al.
Publicado: (2020)

A rare cause of coronary artery aneurysms with possible underlying Kawasaki disease
por: Wang, Xiqiang, et al.
Publicado: (2019)

Duration of dual antiplatelet therapy in acute coronary syndrome
por: Wilson, Simon John, et al.
Publicado: (2017)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
por: Han, Jialun, et al.
Publicado: (2023)

Safety Comparison of Monotherapy Aspirin to Dual Antiplatelet Therapy Following Coronary Artery Bypass Surgery
por: Nei, Scott D., et al.
Publicado: (2022)

Pregnancy in Woman with Kawasaki Disease and Multiple Coronary Artery Aneurysms
por: Avila, Walkiria Samuel, et al.
Publicado: (2018)

Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease
por: Jeon, Soo-kyeong, et al.
Publicado: (2019)

Predictive risk factors of coronary artery aneurysms in Kawasaki disease
por: Woo, Hyang-Ok
Publicado: (2019)

A Ruptured Coronary Artery Aneurysm Secondary to Kawasaki Disease
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Exercise Stress Echocardiography in Kawasaki Disease Patients with Coronary Aneurysms
por: Tedla, Bruke A., et al.
Publicado: (2022)

Coronary changes and cardiac events in children diagnosed with kawasaki disease without initial coronary aneurysm: A multicenter retrospective cohort study
por: Wongbundit, Chanikarn, et al.
Publicado: (2023)

Giant coronary aneurysm caused by Kawasaki disease: consistency between catheter angiography and electrocardiogram gated dual-source computed tomography angiography
por: Hwang, Eun-Ha, et al.
Publicado: (2015)

Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]
por: Gasparovic, Hrvoje, et al.
Publicado: (2012)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial
por: Li, Jingen, et al.
Publicado: (2018)

Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents
por: Wang, Huili, et al.
Publicado: (2015)

Dual antiplatelet treatment after coronary artery bypass surgery
por: Lopez Menendez, Jose, et al.
Publicado: (2015)

Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)

Optimal duration of dual antiplatelet therapy for coronary artery disease
por: Kikkert, W. J., et al.
Publicado: (2018)

Trends in Dual Antiplatelet Therapy Use for Neurointerventional Procedures for the Management of Intracranial Aneurysms
por: Meyer, Benjamen M., et al.
Publicado: (2023)

Proteomics study of serum exosomes in Kawasaki disease patients with coronary artery aneurysms
por: Xie, Xiao-Fei, et al.
Publicado: (2019)

Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial
por: Lin, Si-Yuan, et al.
Publicado: (2021)

Giant coronary artery aneurysm with a thrombus secondary to Kawasaki disease
por: Patil, Sushant, et al.
Publicado: (2008)

Two Cases of Super-Giant Coronary Aneurysms after Kawasaki Disease
por: Lee, Joowon, et al.
Publicado: (2014)

The Relationship Between Hematological Findings and Coronary Artery Aneurysm in Kawasaki Disease
por: Beken, Burçin, et al.
Publicado: (2014)

Giant right coronary artery aneurysm secondary to Kawasaki disease in an infant
por: Algonaid, Omer A., et al.
Publicado: (2019)

Coronary artery aneurysm complicated by pneumothorax with a history of Kawasaki disease
por: Ishida, Shinichi, et al.
Publicado: (2021)

Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms
por: Halyabar, Olha, et al.
Publicado: (2021)

Prediction nomogram for coronary artery aneurysms at one month in Kawasaki disease
por: Tang, Yunjia, et al.
Publicado: (2023)

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease
por: Dummer, Kirsten B., et al.
Publicado: (2023)

Coronary artery aneurysms caused by Kawasaki disease in an adult: A case report and literature review
por: He, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ui91a0k9j27lk6f41bl2eujro